Table 3.
Cry j 1 R2 values |
Cohort | Cry j 1 p values | Cohort | ||||||
LIJ E+ |
NLJ E+ |
LIJ IgE− |
LIJ E+ |
NLJ E+ |
LIJ IgE− |
||||
Cohort | LIJ E+ | 0.34 | 0.19 | Cohort | LIJ E+ | <0.001 | 0.003 | ||
NLJ E+ | 0.34 | 0.09 | NLJ E+ | <0.001 | 0.043 | ||||
LIJ IgE− | 0.19 | 0.09 | LIJ IgE− | 0.003 | 0.043 | ||||
Cry j 2 R2 values |
Cohort | Cry j 2 p values | Cohort | ||||||
LIJ E+ |
NLJ E+ |
LIJ IgE− |
LIJ E+ |
NLJ E+ |
LIJ IgE− |
||||
Cohort | LIJ E+ | 0.16 | 0.4 | Cohort | LIJ E+ | 0.001 | <0.001 | ||
NLJ E+ | 0.16 | 0.14 | NLJ E+ | 0.001 | 0.002 | ||||
LIJ IgE− | 0.4 | 0.14 | LIJ IgE− | <0.001 | 0.002 | ||||
Cry j IFR R2 values |
Cohort | Cry j IFR p values | Cohort | ||||||
LIJ E+ |
NLJ E+ |
LIJ IgE− |
LIJ E+ |
NLJ E+ |
LIJ IgE− |
||||
Cohort | LIJ E+ | n.a. | n.a. | Cohort | LIJ E+ | n.a. | n.a. | ||
NLJ E+ | n.a. | 0.03 | NLJ E+ | n.a. | 0.293 | ||||
LIJ IgE− | n.a. | 0.03 | LIJ IgE− | n.a. | 0.293 |